Adam Telner
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 3
- Diabetes Management and Research 2
- Adrenal Hormones and Disorders 1
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
- Pituitary Gland Disorders and Treatments 1
-
- Medication Adherence and Compliance 1
- Co-authors
- Norman Kalant (1 shared paper)Teik Chye Ooi (1 shared paper)Brien G. Benoit (1 shared paper)SUMER BELBEZ PEK (1 shared paper)Stefan S. Fajans (1 shared paper)David H. Zackon (1 shared paper)Gerard H. Jansen (1 shared paper)Robert L. Crowther (1 shared paper)
- Journals
- The Lancet (2 papers)Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (2 papers)Atherosclerosis (1 paper)Canadian Journal of Diabetes (1 paper)Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Adam Telner
9 papers receiving 2.7k citations
Adam Telner's Hit Papers
Peers
Comparison fields: 5 of 74
- Endocrinology, Diabetes and Metabolism 2.2k
- Pharmacology 315
- Nephrology 118
- Cardiology and Cardiovascular Medicine 299
- Surgery 569
Countries citing papers authored by Adam Telner
This map shows the geographic impact of Adam Telner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Telner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Telner more than expected).
Fields of papers citing papers by Adam Telner
This network shows the impact of papers produced by Adam Telner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Telner. The network helps show where Adam Telner may publish in the future.
Co-authors
The 13 scholars most cited alongside Adam Telner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 3 | 1974 | 6 | |
| 4 | 2008 | 5 | |
| 5 | Adrenal cortical carcinoma: an unusual cause of hyperaldosteronism. | 1983 | 3 |
| 6 | 1977 | 3 | |
| 7 | 2004 | 3 | |
| 8 | 2016 | 1 | |
| 9 | 2005 | 1 |
About Adam Telner
Adam Telner is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice, Pharmacy, Complementary and alternative medicine and Cancer Research, having authored 9 papers that have together received 2.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Diabetes Management and Research (2 papers), Adrenal Hormones and Disorders (1 paper), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Medication Adherence and Compliance (1 paper), Adrenal and Paraganglionic Tumors (1 paper), Pituitary Gland Disorders and Treatments (1 paper) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Pharmacology (315 citations), Nephrology (118 citations), Cardiology and Cardiovascular Medicine (299 citations) and Surgery (569 citations). Adam Telner has collaborated with scholars based in United States and Canada. Frequent co-authors include Norman Kalant, Teik Chye Ooi, Brien G. Benoit, SUMER BELBEZ PEK, Stefan S. Fajans, David H. Zackon, Gerard H. Jansen, Robert L. Crowther, Hasnain M. Khandwala and Julie Y. Cho. Their work appears in journals such as The Lancet, Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Atherosclerosis, Canadian Journal of Diabetes and Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.